Navigation Links
MRI Can Spot Presymptomatic MS
Date:12/10/2008

A third of patients with suspect scans develop the disease within 5 years, study finds

WEDNESDAY, Dec. 10 (HealthDay News) -- Among people whose brain scans show signs of multiple sclerosis but who have no symptoms, one-third will develop MS within about five years, researchers say.

The study included 44 people who had MRI brain scans for a variety of reasons, including migraines or head trauma. The scans detected abnormalities similar to those that occur in MS. After the researchers confirmed these abnormalities were MS-related and ruled out other causes, they followed the patients for a number of years to find out if they developed the disease.

After an average of 5.4 years, 30 percent of the patients had developed MS symptoms. Brain scans showed that another 29 percent of patients had further abnormalities but still showed no symptoms.

"More research is needed to fully understand the risk of developing MS for people with these brain abnormalities, but it appears that this condition may be a precursor to MS," study author Dr. Darin T. Okuda, of the University of California, San Francisco, Medical Center, said in an American Academy of Neurology news release.

Okuda and colleagues, who labeled this condition "radiologically isolated syndrome" (RIS), said further research is needed before any recommendations can be made regarding treatment.

The study was published online Wednesday in the journal Neurology.

In an accompanying editorial, Dr. Dennis Bourdette of the Oregon Health & Science University in Portland noted that seven of the study participants had received MS treatment before they were referred to the UCSF MS center.

"Diagnosing a patient with MS has serious psychosocial and treatment implications, and physicians have an obligation to follow appropriate criteria in making the diagnosis," Bourdette wrote. "Patients must have symptoms to receive a diagnosis. This study sets the stage for establishing a process for evaluating these patients and following them to help determine the risk of developing MS. Until then, we should not tell them that they have MS or treat them with disease-modifying therapies. For now, it's best to remember the wise advice that we treat the patient, not the MRI scan."

More information

The National Multiple Sclerosis Society has more about diagnosing MS.



-- Robert Preidt



SOURCE: American Academy of Neurology, news release, Dec. 10, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
MRI Can Spot Presymptomatic MS
(Date:4/28/2017)... ... 2017 , ... Accreditation Commission for Health Care (ACHC) is ... (HCAOA). This agreement allows HCAOA members to receive special pricing on ACHC’s Home ... University (AU) educational resources that help prepare HCAOA members for ACHC Accreditation. , ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... Horizon Blue ... affirmed the company’s credit rating of “A” and its outlook as “stable.” At the ... capital reserves, which have fallen in recent years, dip below “capital adequacy” thresholds required ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... . These lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on ... or disconnect ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
(Date:4/19/2017)... PUNE, India , April 19, 2017 ... Type and Application, Forecast to 2022 report has covered and ... provides statistics and information on market size, shares and growth ... with major drivers, challenges and opportunities in the global market. ... Browse 152 Tables and ...
(Date:4/19/2017)... , April 19, 2017 ... stimulate an immune response in pets such as ... products are of various types such as Attenuated ... Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines. Attenuated ... as virus or bacteria, which have been weakend ...
Breaking Medicine Technology: